Imago BioSciences to Host Virtual Investor Event
- Company to host virtual investor event on Saturday, June 11 at 10:30 AM ET following its June 10th presentation of updated data from Phase 2 studies of...
Source: globenewswire.com
Page 18 - Presentation Title News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Presentation Title. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Presentation Title Today - Breaking & Trending Today
Oncoinvent AS: Data From the Ongoing Radspherin RAD-18-002 Phase 1 Trial in Colorectal Cancer Patients to Be Presented at the 2022 ASCO Annual Meeting
All dose levels of Radspherin were well tolerated with a maximum dose level toxicity not reached in the RAD-18-002 study. Radspherin is currently being evaluated in two ongoing Phase 1 trials for
Source: finanznachrichten.de
DDW22: SonarMD Data Shows Hidden Impact of Mental Health on IBD Costs, Company Expands Access to Support Services
CHICAGO--(BUSINESS WIRE)--May 23, 2022--
Source: wsiltv.com
MEI Pharma, Inc.: MEI Pharma and Kyowa Kirin Announce Acceptance of Two Abstracts for Presentation at the European Hematology Association 2022 Hybrid Congress
MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical
Source: finanznachrichten.de
LogicBio Therapeutics Announces Upcoming Presentations on GeneRide Development Candidate and Multiple Advancements in AAV Manufacturing Processes at ASGCT Annual Meeting
/PRNewswire/ -- LogicBio® Therapeutics, Inc. (Nasdaq: LOGC), a clinical-stage genetic medicine company, today announced that it will present four abstracts...
Source: prnewswire.com